Several classes of medication effectively treat anxiety, and the right choice depends on the type of anxiety, how quickly you need relief, and how long you’ll need treatment. SSRIs (selective serotonin reuptake inhibitors) are the most widely recommended first-line option, with sertraline (Zoloft) and escitalopram (Lexapro) topping most current treatment guidelines. But they’re far from the only tools available, and understanding how each class works can help you have a more productive conversation with your prescriber.
SSRIs: The Standard First Choice
SSRIs work by preventing your brain from reabsorbing serotonin too quickly, which leaves more of it available between nerve cells. Over time, this triggers a cascade of changes: reduced inflammation in the brain, increased growth of new neural connections, and a gradual recalibration of the circuits involved in fear and worry. That “over time” part matters. SSRIs typically take four to six weeks before you notice a meaningful difference, and the first week or two can actually feel worse as your body adjusts.
Current guidelines from the UK’s National Health Service and other bodies position sertraline as the go-to first-line SSRI for generalized anxiety, social anxiety, panic disorder, and PTSD. Escitalopram is an alternative first-line pick, particularly for social anxiety. If those don’t work after a full 12-week trial, second-line SSRIs include fluoxetine (Prozac), paroxetine (Paxil), and citalopram (Celexa). Each has a slightly different dosing range: sertraline targets 50 to 200 mg per day, escitalopram 10 to 30 mg, and fluoxetine 20 to 80 mg.
In clinical trials for generalized anxiety disorder, escitalopram and sertraline roughly doubled the odds of full remission compared to placebo. A large network meta-analysis published in Frontiers in Pharmacology found that venlafaxine, escitalopram, and sertraline all showed strong remission rates, though no single SSRI dramatically outperforms the others. The real differentiator is usually side effects and individual tolerance.
SNRIs: When SSRIs Aren’t Enough
SNRIs do everything SSRIs do, plus they also boost norepinephrine, a chemical involved in alertness and the body’s stress response. Venlafaxine (Effexor XR) is the primary SNRI for anxiety, recommended as a second-line treatment when SSRIs prove ineffective. Its target dose ranges from 75 to 300 mg per day. Duloxetine (Cymbalta) is another option, typically dosed between 60 and 120 mg daily.
Venlafaxine performed particularly well in remission studies, with odds of remission about 2.3 times higher than placebo. It’s considered a first-line treatment for PTSD alongside SSRIs. The trade-off is that SNRIs can cause more noticeable blood pressure increases at higher doses and may produce more intense discontinuation symptoms if stopped abruptly.
Common Side Effects of Antidepressants
The side effects of SSRIs and SNRIs are one of the main reasons people switch medications or stop taking them. In real-world surveys (not controlled trials, where people are more closely monitored), the most frequently reported problems are sexual dysfunction, affecting roughly 56% of users, drowsiness or sleepiness in about 53%, and weight gain in around 49%. Dry mouth, insomnia, fatigue, and nausea each affect somewhere between 14% and 19% of people.
These numbers look high, but a few things are worth knowing. Many side effects are strongest in the first two weeks and fade as your body adjusts. Sexual side effects, unfortunately, tend to be more persistent. There’s no strong evidence that one SSRI causes dramatically fewer side effects than another across the board, so finding the right fit often involves some trial and error. If one medication causes intolerable drowsiness or weight gain, switching to a different SSRI can sometimes solve the problem.
Benzodiazepines: Fast Acting but Short Term
Benzodiazepines like alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin) work within minutes to hours, not weeks. They enhance the activity of a brain chemical called GABA, which essentially slows down overactive nerve signaling. For someone in the grip of a panic attack or severe acute anxiety, that rapid relief can feel life-changing.
The catch is significant. Guidelines consistently recommend limiting benzodiazepine use to less than four weeks. Long-term use causes physical dependence, cognitive impairment (problems with memory and thinking speed), and increased risk of falls and fractures, particularly in older adults. Interestingly, lorazepam’s performance in clinical remission studies for generalized anxiety was not statistically better than placebo, which suggests that while benzodiazepines suppress anxiety symptoms in the moment, they may not drive the deeper brain changes needed for lasting improvement.
Benzodiazepines are most useful as a short bridge while waiting for an SSRI or SNRI to reach full effect, or for occasional use during particularly intense anxiety episodes. They are not a standalone long-term treatment.
Buspirone: A Non-Addictive Alternative
Buspirone (Buspar) occupies a unique niche. The FDA approved it specifically as a non-addictive, non-sedating alternative to benzodiazepines for generalized anxiety. It doesn’t cause the drowsiness or dependence risk that comes with benzodiazepines, and it doesn’t carry the sexual side effects common with SSRIs.
The downsides keep it from being a first-line pick. Relief takes one to three weeks to appear, it has no effect on coexisting depression (which frequently accompanies anxiety), and its short duration in the body means you need to take it two to three times per day. It also may not be as effective as benzodiazepines for acute symptom control. Still, for people who can’t tolerate SSRIs or who have a history of substance use that makes benzodiazepines risky, buspirone is a solid option.
Hydroxyzine: An Antihistamine That Calms Anxiety
Hydroxyzine (Vistaril) is an antihistamine, not a traditional psychiatric medication, but it has genuine anxiety-reducing effects. Studies show it works better than placebo for anxiety, and it has two practical advantages: no rebound anxiety when you stop taking it, and withdrawal symptoms that are essentially no different from placebo. It works relatively quickly, making it useful for situational anxiety or as an as-needed option.
The main limitation is sedation. Hydroxyzine makes most people drowsy, which can be a benefit at bedtime but a problem during the day.
Medications for Specific Anxiety Disorders
Not all anxiety is the same, and the best medication can depend on your specific diagnosis. For panic disorder, SSRIs remain first-line, but if they fail after 12 weeks, older tricyclic antidepressants like imipramine or clomipramine are recommended next. Tricyclics are effective but come with a heavier side effect burden: weight changes, sexual dysfunction, dry mouth, drowsiness, and potential liver and heart complications. They interact with a long list of other medications and require careful monitoring.
For obsessive-compulsive disorder, SSRIs are again the starting point, but clomipramine specifically has a long track record of effectiveness when SSRIs fail. Some people with OCD that resists both SSRIs and clomipramine benefit from adding a low-dose antipsychotic medication.
Social anxiety disorder follows a similar ladder: sertraline or escitalopram first, then paroxetine or venlafaxine, with older medications like moclobemide or phenelzine reserved for cases that don’t respond to standard treatments. PTSD guidelines place sertraline, paroxetine, and venlafaxine as equally valid first-line choices.
What to Expect When Starting or Stopping
The first few weeks on an SSRI or SNRI are often the hardest. Side effects like nausea, jitteriness, and disrupted sleep tend to peak early and then settle. The anxiety-reducing benefits lag behind, typically becoming noticeable around week four to six. This gap, where you feel side effects but not yet benefits, is when many people are tempted to quit. Sticking with it through that window, assuming the side effects are tolerable, is one of the most important factors in treatment success.
Stopping these medications also requires patience. Antidepressant discontinuation syndrome affects a significant number of people who quit abruptly. Symptoms begin within two to four days of stopping and include flu-like achiness, dizziness, nausea, vivid nightmares, and electric shock-like sensations that many people describe as “brain zaps.” Mood changes like irritability and rebound anxiety are also common. Resuming the medication at the previous dose usually resolves symptoms within 24 hours. The safe approach is a gradual taper over weeks or months, guided by your prescriber, with the pace adjusted based on how you respond.
Pregabalin: A Third-Line Option
Pregabalin, originally developed for nerve pain and seizures, is positioned as a third-line treatment for generalized anxiety when SSRIs and SNRIs have both failed. It works through a different mechanism than antidepressants, calming overactive nerve signals by blocking certain calcium channels. Current guidelines reserve it for treatment-resistant cases. Its remission data in clinical trials was not statistically superior to placebo in the network meta-analysis, though individual response varies. It does carry a risk of dependence and is a controlled substance in many countries.